RA Capital Management, L.P.
84 holdingsFiling period: 2026-06-30Current AUM: $10.20Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | — | Ascendis Pharma A/S | 10.28M | $2.74B | $2.74B | 26.89% | -- | 2026-06-30 |
| 2 | PBLS | Parabilis Medicines Inc | 28.93M | $791.9M | $767.0M | 7.52% | -- | 2026-06-30 |
| 3 | RYTM | Rhythm Pharmaceuticals Inc | 6.67M | $740.2M | $614.5M | 6.03% | -- | 2026-06-30 |
| 4 | PCVX | Vaxcyte Inc | 11.47M | $667.0M | $696.2M | 6.83% | -- | 2026-06-30 |
| 5 | SION | Sionna Therapeutics Inc | 9.91M | $435.7M | $38.3M | 0.38% | -- | 2026-06-30 |
| 6 | TYRA | Tyra Biosciences Inc | 12.20M | $389.6M | $262.5M | 2.57% | -- | 2026-06-30 |
| 7 | EWTX | Edgewise Therapeutics Inc | 8.39M | $341.0M | $331.8M | 3.25% | -2,035,707 | 2026-06-30 |
| 8 | — | Newamsterdam Pharma Co NV | 9.55M | $323.7M | $323.7M | 3.17% | -- | 2026-06-30 |
| 9 | COAG | Hemab Therapeutics Holdings | 7.81M | $286.8M | $299.9M | 2.94% | -- | 2026-06-30 |
| 10 | SEPN | Septerna Inc | 7.00M | $234.3M | $308.8M | 3.03% | -- | 2026-06-30 |
| 11 | BCAX | Bicara Therapeutics Inc | 7.26M | $215.4M | $126.8M | 1.24% | -- | 2026-06-30 |
| 12 | MLYS | Mineralys Therapeutics Inc | 7.69M | $207.6M | $162.5M | 1.59% | -- | 2026-06-30 |
| 13 | — | GH Research PLC | 7.64M | $205.3M | $205.3M | 2.01% | -39,884 | 2026-06-30 |
| 14 | IRON | Disc Medicine Inc | 2.45M | $179.2M | $195.8M | 1.92% | -- | 2026-06-30 |
| 15 | SGP | Spyglass Pharma Inc | 8.02M | $178.6M | $247.9M | 2.43% | -- | 2026-06-30 |
| 16 | ARTV | Artiva Biotherapeutics Inc | 17.96M | $174.2M | $76.7M | 0.75% | +8.10M | 2026-06-30 |
| 17 | JANX | Janux Therapeutics Inc | 11.19M | $171.9M | $193.1M | 1.89% | -- | 2026-06-30 |
| 18 | TSHA | Taysha Gene Therapies Inc | 23.56M | $160.4M | $100.1M | 0.98% | -- | 2026-06-30 |
| 19 | BCRX | Biocryst Pharmaceuticals Inc | 15.83M | $158.3M | $128.2M | 1.26% | -- | 2026-06-30 |
| 20 | — | Wave Life Sciences Ltd | 26.98M | $156.7M | $156.7M | 1.54% | -- | 2026-06-30 |
| 21 | NUVL | Nuvalent Inc-A | 1.25M | $153.9M | $153.9M | 1.51% | -1,287,689 | 2026-06-30 |
| 22 | ABVX | Abivax SA-ADR | 1.13M | $150.9M | $98.5M | 0.97% | -- | 2026-06-30 |
| 23 | ORKA | Oruka Therapeutics Inc | 1.55M | $147.9M | $148.9M | 1.46% | -- | 2026-06-30 |
| 24 | CLYM | Climb Bio Inc | 11.30M | $147.4M | $108.1M | 1.06% | -- | 2026-06-30 |
| 25 | SLDB | Solid Biosciences Inc | 12.04M | $120.2M | $74.5M | 0.73% | +2.70M | 2026-06-30 |
← Scroll →
Page 1 of 4